These data consolidate the notion that hepatic mGluR5 has a relevant role in NAFLD development and encourage further studies to better understand the interconnection between this receptor and the multiple nuclear factors involved in the pathogenesis of this disease. The gene discussed is GRM5; the disease is metabolic dysfunction-associated steatotic liver disease.